Fri 16 Mar 2007
Dear Friends and Family:
Thanks so much for your prayers for Marty this week. All in all, this was probably the best week we’ve had during chemotherapy. We’ve now completed seven of the eight treatments. Our final chemo session is Tuesday, March 27.
Dr. Lee's report encouraged us. Marty's tumor marker 2729 drawn a month ago-- two weeks after the first Taxol treatment—fell from 325 to 200. [It started greater than 5,000.] This particularly encouraged me because it shows the Taxol is effective like the first drug combination. The blood count report was good as well. Marty's hemoglobin was up to 9.9, the white count was 15,000, and the platelets 200,000. [all acceptable.] She got another Aranesp injection to stimulate the red cells.
Dr. Lee outlined the remaining schedule. About a week after Marty’s last chemotherapy, she starts hormonal therapy, Femara; this is a pill taken as an ongoing, daily, long-term treatment. It is an aromatase inhibitor, which sounds like a deodorant but isn't; it blocks the body from forming estrogen hormone from fat cells in post-menopausal women—and most of us have plenty of those kind of cells. The tumor, which grows when stimulated by estrogen, doesn't progress when she takes the drug—at least, that's the theory. A month later, in early May, Marty goes through the round of scans again. Then a decision is reached whether to add a targeted radiation to the treatment for any visible, residual disease. Also, a lumpectomy could be considered if any visible tumor remains